Introduction
Polymers play a central role in biomedical applications due to their versatility, tunable properties, and biocompatibility. By engineering polymers, scientists can control structural and mechanical properties, degradation rates, and bioactivity, making them ideal materials for next-generation biomedical devices and therapies.
Both natural and synthetic polymers play essential roles in biomedical applications. Natural polymers, such as collagen, gelatin, chitosan, and alginate, are derived from biological sources and offer excellent biocompatibility and bioactivity. Alternatively, synthetic polymers can be precisely engineered to achieve controlled physical, chemical, and degradation properties with high reproducibility. Common examples include poly (lactic acid) (PLA), poly (glycolic acid) (PGA), and polyethylene glycol (PEG), all widely used in medical and pharmaceutical fields. Composites of both synthetic and natural polymers utilize the unique advantages of both types.
Polymers are employed across a broad spectrum of biomedical applications, including drug delivery systems, tissue engineering, medical devices and implants, and diagnostic technologies. In drug delivery, polymers enable the development of controlled-release systems that enhance therapeutic efficiency. In tissue engineering, biodegradable polymeric scaffolds, designed to mimic the natural extracellular matrix (ECM), support cell adhesion and tissue regeneration. For medical devices and implants, polymers offer a unique combination of mechanical strength, flexibility, and biocompatibility.
Polymer Compounding
While polymers are fundamental to modern biomedical science, single-component polymers often fail to meet the diverse and demanding requirements of biological environments. Polymer compounding, the process of blending a base polymer with additives such as plasticizers, fillers, active agents, biodegradable components, nanomaterials, or other polymers, addresses this limitation by producing materials with tailored functional properties. The resulting compounded materials can be processed into films, fibers, scaffolds, or nanoparticles for various biomedical applications. In the field of biomaterials, polymer compounding has been used to help develop hydrogels with better water retention,1 rubber composites with improved sustainability,2 and biodegradable fillers for food products,3 to name a few. Through this approach, biomedical engineers can precisely optimize biocompatibility, mechanical strength, degradation behavior, and drug release profiles, enabling the development of advanced materials designed for specific medical needs.
Micro Compounding
Polymer compounding is traditionally performed using standard, production-scale compounders. However, these large systems are often unsuitable for research and development when developing novel polymer formulations. Micro compounders address this limitation by offering several key advantages. Their small batch capacity allows efficient compounding with minimal material waste, an important factor when working with expensive or limited materials. They also provide precise control over processing parameters, enabling researchers to replicate and optimize conditions at the laboratory scale. In addition, their ability to support rapid formulation iterations significantly accelerates the development process. Importantly, micro compounders operate using the same mechanical principles as full-scale systems, ensuring that successful laboratory formulations can be reliably scaled up to pilot or production levels when required.
Xplore line of micro compounders are class-leading instruments known for the quality of their twin screws and the mixing barrels (shown in Figure 1). The mixing barrels of Xplore systems are fluid-tight, abrasion resistant, and chemically nonreactive, making them compatible with most materials and inclusions. Three separate heating zones are included to maximize environmental control and ensure reproducibility. In addition to the polymer melt, another output from the Xplore systems is rheological data. Torque, shear stress, and melt temperature can all be monitored over time and compared to production-scale compounding.

In addition to micro compounders, Xplore also offers a line of polymer shaping instruments (Figure 2), including an injection molder, microfiber line, pelletizer, and more. This enables polymers to be shaped precisely for their application, from 3D printing to tensile testing. Many of these instruments can be directly integrated with micro compounders to improve throughput and minimize operator intervention.



Polymer Fibers
Polymer fibers with diameters below one micron, offer a high surface-area-to-volume ratio, tunable porosity, and excellent mechanical flexibility. These characteristics make them highly valuable in biomedical applications, where surface interactions, diffusion, and biocompatibility are critical. In tissue engineering, fibrous scaffolds closely mimic the ECM, supporting cell adhesion, proliferation, and differentiation. In drug delivery, fibers enable controlled and localized release of therapeutic agents through diffusion or degradation-based mechanisms. Fiber mats are widely used in wound dressings due to their breathability, ability to maintain a moist healing environment, and capacity for antimicrobial or bioactive agent incorporation. Emerging applications also include biosensors, implant coatings, and regenerative medicine scaffolds, where their customizable structure and composition offer significant design flexibility. Nanofibers can be fabricated by many different methods, but electrospinning stands out for its ability to fabricate fiber with tunable properties, room-temperature operation, and large range in material compatibility.4
Electrospinning
Electrospinning is a versatile technique used to produce ultra-fine polymer fibers by applying a high-voltage field to a polymer solution. As the charged polymer jet is ejected from a needle toward a grounded collector, it stretches and solidifies into continuous fibers. This method allows precise control over fiber diameter, alignment, and morphology. Electrospun fibers can be tuned to mimic the ECM of complex, multi-layered tissues such as nerve conduits or blood vessel scaffolds.5 Bioactives, or pharmaceuticals can also be incorporated to improve therapeutic effects. Unlike many other fabrication methods, using sustainable polymers and solvents improves biomimetic ability without compromising material strength;6 this is critical for the long-term viability of electrospun biomaterials. For projects or labs utilizing the unique properties of nanofibers, electrospinning is a highly effective, tunable, and sustainable solution.
The LE-series of electrospinning systems from Fluidnatek, which Nanoscience Analytical leverages, are the perfect tools for the reproducible fabrication of micro and nano-scaled fibers. These systems are engineered to optimize control over the electrospinning process, ensuring consistent, high-quality nanofiber fabrication. These systems provide a high level of control over environmental conditions ensuring reproducibility and consistency. The systems are equipped for simultaneous multi-solution processing, utilize interchangeable emitter and collector types, and can handle challenging solvents.


Fluidnatek equipment scales seamlessly from benchtop systems (LE-50) to fully automated equipment for industrial manufacturing (Fluidnatek-HT). This permits researchers and manufacturers to translate laboratory-scale research to large-scale production processes with ease, all while maintaining the highest sample quality. Importantly, recipes developed on smaller tabletop units can be reliably transferred to larger volume instruments.
Specialized systems for biomedical applications are also available offering finer process control and increased batch-to-batch consistency. These systems are ideal when cleanliness and sterility are essential for medical applications and are cGMP and ISO-13485 certifiable.
Technical Consulting and Development
Having specialized equipment or expertise is not required for generating innovative ideas; however, they are necessary for realizing these ideas. Depending on the instruments needed to fabricate and analyze a sample, the cost of entry can be a significant barrier to progress. In addition to the initial equipment purchase, new operators need to be trained, and resources must be set aside for regular maintenance. For individual, early-stage projects, these costs are often unjustifiable.
Nanoscience Analytical provides the instruments, expertise, and industry knowledge needed to realize innovative ideas with electrospinning and micro compounding. Their instruments are top-of-the-line, and their team of application scientists have extensive experience. From proof-of-concept samples to process development for manufacturing, Nanoscience Analytical offers support for every stage of a project’s lifespan.
References
- Mukherjee, K. Hybrid hydrogel fabrication via twin-screw extrusion for superior water retention and purity. Discover Polymers. 2025, 2 (1). https://doi.org/10.1007/s44347-025-00026-4. ↩︎
- Devney. Increasing the Sustainability of Hevea Natural Rubber Composites Utilizing Surface Modified Fly Ash and Micro-Compounding of Carbon-Filled Natural Rubber Composites. OhioLINK. http://rave.ohiolink.edu/etdc/view?acc_num=osu1721317096650493 (accessed 2025-10-6). ↩︎
- Sasimowski, E.; Majewski, Ł.; Grochowicz, M. Efficiency of Twin-Screw extrusion of biodegradable poly (Butylene Succinate)-Wheat bran blend. Materials 2021, 14 (2), 424. https://doi.org/10.3390/ma14020424. ↩︎
- Chinnappan, B. A.; Krishnaswamy, M.; Xu, H.; Hoque, M. E. Electrospinning of Biomedical Nanofibers/Nanomembranes: Effects of process parameters. Polymers 2022, 14 (18), 3719. https://doi.org/10.3390/polym14183719. ↩︎
- Lugoloobi, I.; Yuanhao, W.; Marriam, I.; Hu, J.; Tebyetekerwa, M.; Ramakrishna, S. Electrospun biomedical nanofibers and their future as intelligent biomaterials. Current Opinion in Biomedical Engineering 2022, 24, 100418. https://doi.org/10.1016/j.cobme.2022.100418. ↩︎
- Mosher, C. Z.; Brudnicki, P. a P.; Gong, Z.; Childs, H. R.; Lee, S. W.; Antrobus, R. M.; Fang, E. C.; Schiros, T. N.; Lu, H. H. Green electrospinning for biomaterials and biofabrication. Biofabrication 2021, 13 (3), 035049. https://doi.org/10.1088/1758-5090/ac0964. ↩︎